Literature DB >> 19468255

Symmetric division and expression of its regulatory gene Numb in human cervical squamous carcinoma cells.

Huaizeng Chen1, Xiaojun Chen, Feng Ye, Weiguo Lu, Xing Xie.   

Abstract

OBJECTIVE: To investigate the mode of cell division and Numb expression in cervical squamous cells.
METHOD: We measured the cleavage angles of cervical squamous epithelia basal cells and Numb protein expression in 50 cases of cervical squamous cell carcinomas (CSCC), 59 cervical intraepithelial neoplasias (CIN) grade II-III, 21 CIN grade I and 48 controls.
RESULTS: We found an increase in horizontal divisions in CIN grade I and a decrease in horizontal divisions in CIN grade II-III. Numb expression had a tendency to be stronger from control to CSCC. In CSCC there was a significantly higher expression of mRNA for the Numb-PRRL isoform but not for the Numb-PRRS isoform.
CONCLUSION: Our findings suggest that in the initial stage of CSCC, carcinomatous cells may acquire an increase of symmetric division by altering cleavage orientation and proliferation. Expression of Numb protein in Cervical squamous epithelia and an increased expression of Numb-PRRL isoforms may be among the mechanisms involved in the genesis of CSCC. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19468255     DOI: 10.1159/000209393

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  13 in total

1.  Increased Numb protein expression predicts poor clinical outcomes in esophageal squamous cell carcinoma patients.

Authors:  Zhenguo Liu; Canqiao Luo; Weixiong Yang; Kefeng Wang; Chuang Hu; Jianyong Zou; Hua Zhu; Liwu Fu; Jing Nie; Chao Cheng
Journal:  Cancer Biol Ther       Date:  2017-12-18       Impact factor: 4.742

2.  Numb exon 9 inclusion regulates Integrinβ5 surface expression and promotes breast cancer metastasis.

Authors:  Yangjing Zhang; Sascha E Dho; Kamal Othman; Craig D Simpson; Jessica Lapierre; Andrew Bondoc; C Jane McGlade
Journal:  Oncogene       Date:  2022-02-18       Impact factor: 8.756

3.  The tumor suppressive role of NUMB isoform 1 in esophageal squamous cell carcinoma.

Authors:  Junmou Hong; Zhenguo Liu; Hua Zhu; Xin Zhang; Yongju Liang; Shiyuan Yao; Fang Wang; Xiaoyun Xie; Bo Zhang; Tao Tan; Liwu Fu; Jing Nie; Chao Cheng
Journal:  Oncotarget       Date:  2014-07-30

4.  Role of Numb expression and nuclear translocation in endometrial cancer.

Authors:  Chao Wang; Tao Cui; Weiwei Feng; Huashun Li; Lina Hu
Journal:  Oncol Lett       Date:  2015-01-27       Impact factor: 2.967

5.  NUMB and NUMBL differences in gene regulation.

Authors:  José Manuel García-Heredia; Amancio Carnero
Journal:  Oncotarget       Date:  2018-01-11

6.  The Expression and Function of NUMB in Endometrial Cancer and the Interaction with HDM2 and P53.

Authors:  Chao Wang; Weiwei Feng; Chuyao Zhang
Journal:  J Cancer       Date:  2015-08-29       Impact factor: 4.207

7.  Aberrant expression of Notch1/numb/snail signaling, an epithelial mesenchymal transition related pathway, in adenomyosis.

Authors:  Shasha Qi; Xingbo Zhao; Mingjiang Li; Xiaohui Zhang; Zhenzhen Lu; Chunrun Yang; Chunhua Zhang; Hui Zhang; Na Zhang
Journal:  Reprod Biol Endocrinol       Date:  2015-08-26       Impact factor: 5.211

8.  miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes.

Authors:  Pei-Shi Hung; Chung-Ji Liu; Chung-Shan Chou; Shou-Yen Kao; Cheng-Chieh Yang; Kuo-Wei Chang; Ting-Hui Chiu; Shu-Chun Lin
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

9.  Numb-like (NumbL) downregulation increases tumorigenicity, cancer stem cell-like properties and resistance to chemotherapy.

Authors:  José M García-Heredia; Eva M Verdugo Sivianes; Antonio Lucena-Cacace; Sonia Molina-Pinelo; Amancio Carnero
Journal:  Oncotarget       Date:  2016-09-27

10.  Loss of nuclear NOTCH1, but not its negative regulator NUMB, is an independent predictor of cervical malignancy.

Authors:  Elenaé Vázquez-Ulloa; Ana Clara Ramos-Cruz; Diddier Prada; Alejandro Avilés-Salas; Alma Delia Chávez-Blanco; Luis A Herrera; Marcela Lizano; Adriana Contreras-Paredes
Journal:  Oncotarget       Date:  2018-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.